Ketogenic Metabolic Therapy: A New Bridge Between Functional and Conventional Psychiatry

Why Metabolic Psychiatry Is Gaining Traction

Over the past few years, metabolic psychiatry has quickly moved from a promising idea to a legitimate area of clinical research. Previously thought to be a fad weight loss diet, its impact in the realm of psychiatry is becoming increasingly evident. As we learn more about the role of insulin resistance, inflammation, and mitochondrial health in shaping mental and cognitive health, it makes sense that nutritional strategies like the ketogenic diet are garnering well-deserved attention. What’s especially exciting is that the newest data isn’t coming from wellness blogs or biohacker podcasts—it’s coming from academic psychiatry departments, clinical trials, and published literature. In what feels like a monumental shift, we’re seeing a bridge form between functional psychiatry and traditional evidence-based care.

How Ketosis Impacts Brain Function

Achieving nutritional ketosis can support the brain in numerous ways, with many more mechanisms likely to be elucidated. Unlike other nutritional approaches, ketogenic diets elicit a measurable shift in the body’s physiology and metabolism. Instead of relying on glucose for fuel, the body and brain begin to take advantage of an alternative, arguably more efficient energy source—ketones. Ketones have been shown to improve mitochondrial efficiency and lower neuroinflammation, the latter via NLRP3 inflammasome inhibition (Youm et al., 2015).

The best-known ketone, β-hydroxybutyrate (BHB), has shown therapeutic promise in myriad conditions ranging from neurologic and psychiatric illnesses to metabolic diseases like Type 2 Diabetes and even some forms of cancer. Pioneers in the field of metabolic psychiatry, including Drs. Chris Palmer, Shebani Sethi, and Georgia Ede, have begun to unravel the complex relationship between mitochondrial and metabolic health and psychiatric illness, offering new solutions to those struggling with difficult to treat psychiatric disorders.

The New Wave of Clinical Studies on Ketogenic Metabolic Therapy

There has been an influx of studies supporting ketogenic metabolic therapy (KMT) in the treatment of various psychiatric disorders. The following is just an assortment of the exciting updates from the growing body of KMT literature:

• Ketogenic diet intervention on metabolic and psychiatric health in bipolar disorder and schizophrenia (2024) — In a 4-month, single-arm pilot trial of 23 people with bipolar disorder or schizophrenia and comorbid metabolic problems, Sethi et al. (2024) found that the ketogenic diet reversed metabolic syndrome in all participants and led to marked improvements in psychiatric symptoms, highlighting what they describe as “dual metabolic-psychiatric benefits from ketogenic therapy.”
• Complete remission of depression and anxiety using a ketogenic diet (2024) — In a retrospective case series of three adults with long-standing major depression, generalized anxiety disorder, and complex comorbidities, KMT led to complete remission of both depressive and anxiety symptoms within 7-12 weeks (measured via PHQ-9 and GAD-7), alongside substantial weight loss (10.9–14.8% of body weight) and improved metabolic markers (Calabrese et al., 2024).
• A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder (2025) — In a fascinating recent study, college students with diagnosed major depression who added a well-formulated ketogenic diet (WFKD) to usual care experienced a ~69% drop in self-reported depressive symptoms (via PHQ-9) and ~71% drop in clinician-rated depression scores (via Hamilton Rating Scale for Depression), along with improved well-being, cognitive performance, body composition, and neuroplasticity biomarkers (e.g. +32% BDNF) (Decker et al., 2025).
• Transdiagnostic remission of psychiatric comorbidity using ketogenic metabolic therapy (2024) — In this case report, a personalized ketogenic metabolic therapy protocol led to significant improvements across multiple psychiatric diagnoses — including PTSD, ADHD, and binge-eating disorder — suggesting that KMT may support mental health regardless of the specific disorder, potentially by targeting shared metabolic and neurobiological pathways (Bellamy & Laurent, 2025).

Clinical Considerations for Ketogenic Metabolic Therapy

With the growing body of literature supporting the use of KMT in patients with various psychiatric diagnoses, it’s easy to jump to the conclusion that it’s a therapeutic panacea. In functional psychiatry, however, we know there is no one-size-fits-all approach—whether for diet, supplements, or medications. More data, ideally from randomized controlled trials, are needed to optimize KMT treatment protocols and avoid potential pitfalls.

Many questions remain unanswered. For example: What is the optimal ketone level, and does it differ across diagnoses? Are potential changes in thyroid function clinically meaningful? Who is most likely to benefit from KMT, and what is a reasonable timeframe for trialing it?

While there is still much to learn, KMT appears particularly promising for patients with metabolic dysfunction—such as type 2 diabetes, prediabetes, insulin resistance, or overweight/obesity—as well as for those with treatment-resistant psychiatric conditions. It’s important to remember that KMT is more than a diet; it’s a full-fledged intervention best supported by a multidisciplinary team, including prescribers, dietitians, therapists, and internists. Luckily, growing opportunities in metabolic psychiatry training are making it increasingly feasible to find experienced clinicians.

Ketogenic Metabolic Therapy: A Promising Frontier in Psychiatry

What started as a breakthrough treatment for treatment-resistant pediatric epilepsy and later resurfaced as an effective weight-loss strategy, the ketogenic diet now represents a promising frontier in psychiatry. For decades, the field has largely focused on the monoamine hypothesis and other neurotransmitter-centered models, but shifting attention to brain energy and metabolic health offers a paradigm-changing approach to improving psychiatric symptoms. While more research is needed, the growing body of literature—and the remarkable clinical anecdotes—make the potential of ketogenic metabolic therapy hard to ignore.